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Because of the constant threat posed by emerging infectious diseases and the limitations of existing approaches used
to identify new pathogens, there is a great demand for new technological methods for viral discovery. We describe
herein a DNA microarray-based platform for novel virus identification and characterization. Central to this approach
was a DNA microarray designed to detect a wide range of known viruses as well as novel members of existing viral
families; this microarray contained the most highly conserved 70mer sequences from every fully sequenced reference
viral genome in GenBank. During an outbreak of severe acute respiratory syndrome (SARS) in March 2003,
hybridization to this microarray revealed the presence of a previously uncharacterized coronavirus in a viral isolate
cultivated from a SARS patient. To further characterize this new virus, approximately 1 kb of the unknown virus
genome was cloned by physically recovering viral sequences hybridized to individual array elements. Sequencing of
these fragments confirmed that the virus was indeed a new member of the coronavirus family. This combination of
array hybridization followed by direct viral sequence recovery should prove to be a general strategy for the rapid
identification and characterization of novel viruses and emerging infectious disease.
Introduction
Over the past two decades, technological advances in
molecular biology have fuelled progress in the discovery of
new pathogens associated with human diseases. The identi-
ﬁcation of novel viruses such as hepatitis C virus (Choo et al.
1989), sin nombre virus (Nichol et al. 1993), and Kaposi’s
sarcoma herpesvirus (Chang et al. 1994) has relied upon a
diverse range of modern molecular methods such as
immunoscreening of cDNA libraries, degenerate PCR, and
representational difference analysis, respectively. In spite of
these successes, there remain numerous syndromes with
suspected infectious etiologies that continue to escape
identiﬁcation efforts, in part due to limitations of existing
methodologies for viral discovery (Muerhoff et al. 1997;
Kellam 1998). These limitations, coupled with the constant
threat posed by newly emerging infectious diseases of
unknown origin, necessitate that new approaches be devel-
oped to augment the repertoire of available tools for
pathogen discovery.
We have previously described a prototype DNA microarray
designed for highly parallel viral detection with the potential
to detect novel members of known viral families (Wang et al.
2002). This microarray contained approximately 1600 oligo-
nucleotides representing 140 viruses. Building upon this
foundation, a more comprehensive second-generation DNA
microarray consisting of 70mer oligonucleotides derived
from every fully sequenced reference viral genome in
GenBank (as of August 15, 2002) was constructed. The most
highly conserved 70mers from each virus were selected as
described by Wang et al. (2002) to maximize the probability of
detecting unknown and unsequenced members of existing
families by cross-hybridization to these array elements. On
average, ten 70mers were selected for each virus, totaling
approximately 10,000 oligonucleotides from approximately
1,000 viruses. The objective was to create a microarray with
the capability of detecting the widest possible range of both
known and unknown viruses. This pan-viral microarray was
used as part of the global effort to identify a novel virus
associated with severe acute respiratory syndrome (SARS) in
March 2003, as reported by Ksiazek et al. (2003). We describe
here the experimental details of the microarray methodology
for novel virus identiﬁcation, using the SARS outbreak as an
example.
Results
During the initial phase of research into the etiology of
SARS, an unknown virus was cultured in Vero cells from a
patient suffering from SARS (Ksiazek et al. 2003). Total
nucleic acid puriﬁed from this viral culture, as well as a
control culture, was obtained from the Centers for Disease
Control and Prevention on March 22, 2003. These two
samples, along with additional controls (HeLa cell RNA and
water alone), were ampliﬁed and hybridized within 24 h to the
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elements from the infected culture were derived from two
families: astroviridae and coronaviridae. Table 1 lists the
oligonucleotides from these families with the greatest hybrid-
ization intensity. By comparison, these oligonucleotides
yielded essentially background levels of hybridization in the
various control arrays performed in parallel. The initial
suggestion from this hybridization pattern was that members
of both of these viral families might be present. However,
alignment of the oligonucleotides using ClustalX revealed
that all four hybridizing oligonucleotides from the astrovir-
idae and one oligonucleotide from avian infectious bronchitis
virus (IBV) (GenBank NC_001451), an avian coronavirus,
shared a core consensus motif spanning 33 nucleotides (data
not shown); thus, these ﬁve oligonucleotides behaved essen-
tially as multiple redundant probes for the same sequence.
This motif is known to be present in the 39 UTR of all
astroviruses and the avian coronaviruses (Jonassen et al.
1998), but appears to be absent in the available sequenced
mammalian coronaviruses (bovine coronavirus, murine hep-
atitis virus [MHV], human coronavirus 229E, porcine epi-
demic diarrhea virus, and transmissible gastroenteritis virus).
The other three hybridizing oligonucleotides were derived
from three conserved regions within the ORF1AB polypro-
tein common to all coronaviruses (Figure 1). Based on the
aggregate hybridization pattern, the virus appeared to be a
novel member of the coronavirus family.
To further characterize this virus, we sequenced fragments
of the viral genome using two complementary approaches.
First, BLAST alignment of two of the hybridizing viral
oligonucleotides, one each from bovine coronavirus and
human coronavirus 229E, to the IBV genome indicated that
the oligonucleotides possessed homology to distinct con-
Table 1. Oligonucleotides Hybridizing to Viral Sample
Oligo ID Family Virus Oligo Sequence Identities
to SARS
Virus
a
9626535_1099 Corona IBV TAGAGTAGGTATAAAGATGCCAGTGCCGGGGCCACGCGGAGTAC-
GATCGAGGGTACAGCACTAGGACGCC
29/29
9626535_568 Corona IBV TTATGGGTTGGGATTATCCTAAGTGTGATAGAGCAATGCCTAA-
TTTGTTGCGTATAGCAGCATCCTTAGT
39/43
15081544_766 Corona Bovine corona CTGGCTGTAATGGAGGTAGTTTGTATGTTAATAAACATGCATTC-
CACACTAAACCCTTTTCTAGGGCAGC
44/48
12175745_728 Corona Human 229E AAATGGATGGCTTGTGTTTGTTTTGGAATTGTAATGTGGATATGT-
ACCCTGAATTCTCAATTGTTTGCAG
25/27
9635576_275 Astro Turkey astro GATGCTTGAGAAAAATTGATGCCGAGGCCACGCCGGGTAGGATC-
GAGGGTACAGCATCGGTGCACTAACT
29/32
9635572_255 Astro Ovine astro ATCACTTCAATCCCGAGGCCACGCCGAGTAGGATCGAGGGTAC-
AGGATTGTTTGATTTTTTAATCAATTA
30/32
20514394_269 Astro Avian nephritis ACTTTCCCGAGGCCACGGCGAGTAGCATCGAGGGTACAGGAAA-
GCTGGGACCATTGCATAGTCAACTAAT
28/32
9630726_269 Astro Human astro TGCACATCTGGAAGCCGCGGCCACGCCGAGTAGGAACGAGGGT-
ACAGCTTCCTTCTTTTCTGTCTCTGTT
26/29
Underlined nucleotides represent regions of identity to the SARS coronavirus. Does not include reverse complement oligos.
a BLAST identities to the SARS coronavirus genome (NC_004718).
DOI: 10.1371/journal.pbio.0000002.t001
Figure 1. Prototypical Coronavirus Genome Structure
Red bars indicate physical location of virus microarray DNA elements
mapped to a generic coronavirus genome. Portions of the corona-
virus genome sequenced by physical recovery and PCR methods are
highlighted with homologies to known coronaviruses. Abbreviations:
aa, amino acid; nt, nucleotide
DOI: 10.1371/journal.pbio.0000002.g001
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matches of 42/47 and 26/27, respectively). A pair of PCR
primers was designed to amplify the intervening sequences
between the two conserved regions, and a fragment that
possessed 89% identity over 37 amino acids to MHV, a
murine coronavirus, was obtained (Figure 1; sequence
available as Data S1, found at http://dx.doi.org/10.1371/
journal.pbio.0000002.sd001.).
In a parallel approach, we directly recovered hybridized
viral sequences from the surface of the microarray. This
procedure took advantage of the physical separation achieved
during microarray hybridization, which effectively puriﬁed
the viral nucleic acid from other nucleic acid species present
in the sample. Using a tungsten needle, the DNA microarray
spot corresponding to the conserved 39 UTR motif was
repeatedly scraped and the hybridized nucleic acid was
recovered. This material was subsequently ampliﬁed, cloned,
and sequenced (Figure 2). The largest clone spanned almost
1.1 kb; this fragment encompassed the 39 UTR conserved
motif and extended into the most 39 coding region of the
viral genome. BLAST analysis revealed 33% identity over 157
amino acids to MHV nucleocapsid, thus conﬁrming the
presence of a novel coronavirus (see Figure 1; see Data S1).
We subsequently conﬁrmed results obtained from both
strategies described above by using a random-primed RT-
PCR shotgun sequencing approach that generated contigs
totaling approximately 25 kb of viral genome sequence (see
Data S1).
Discussion
In this report, we have demonstrated the viability of
detecting novel pathogens via cross-hybridization to highly
conserved sequence motifs. With the recent sequencing of the
complete SARS coronavirus genome (GenBank NC_004718)
(Marra et al. 2003; Rota et al. 2003), we were able to
retrospectively determine the degree of nucleotide identity
shared between the hybridizing oligonucleotides and the new
coronavirus genome (see Table 1). Stretches of relatively
uninterrupted nucleotide identity as short as 25 nucleotides
yielded clearly detectable hybridization signal, conﬁrming
that novel viruses with only limited homology to known
viruses can be successfully detected by this strategy.
A key feature of this approach is that direct recovery of
hybridized material from the microarray provides a rapid
route for obtaining sequences of novel viruses. By contrast,
conventional strategies for subsequent sequence identiﬁca-
tion would require time-consuming steps such as library
screening or additional rounds of PCR primer design and
synthesis. In the case of SARS, we were able to ascertain
within 24 h that a novel coronavirus was present in the
unknown sample, and partial genome sequences of this virus
were obtained over the next few days without the need for
speciﬁc primer design. To our knowledge, this is the ﬁrst
demonstration of the feasibility and utility of directly
recovering nucleic acid sequences from a hybridized DNA
microarray. In light of the continuous threat of emerging
infectious diseases, this overall approach will greatly facilitate
the rapid identiﬁcation and characterization of novel viruses.
Materials and Methods
Nucleic acid isolation. Total nucleic acid was puriﬁed using the
automated NucliSens extraction system (BioMerieux, Durham, North
Carolina). Following the manufacturer’s instructions, 100 ll of each
specimen was added to tubes containing 900 ll of prewarmed
NucliSens lysis buffer and incubated at 378C for 30 min with
intermittent mixing. Fifty microliters of silica suspension provided in
the extraction kit was added to each tube and mixed. The mixtures
were then transferred to a nucleic acid extraction cartridge and
loaded onto the extractor workstation for processing. Approximately
50 ll of total nucleic acid eluate was recovered.
Ampliﬁcation. For the culture supernatants, 450 ng of nucleic acid
was used as input for the ampliﬁcation protocol. In parallel, 50 ng of
HeLa cell RNA was used as a positive ampliﬁcation control and water
was used for a negative control. Samples were ampliﬁed using a
random-primer protocol as described by Wang et al. (2002), with the
following modiﬁcations: ﬁrst- and second-strand synthesis were
primed using primer-A (59-GTTTCCCAGTCACGATCNNNNNNN-
NN) followed by PCR ampliﬁcation using primer-B (59-GTTTCCC-
AGTCACGATC) for 40 cycles. Aminoallyl-dUTP was incorporated
into the PCR product using an additional 20 cycles of thermocycling.
A detailed protocol is available as Protocol S1, found at http://
dx.doi.org/10.1371/journal.pbio.0000002.sd002.
Microarray hybridization and analysis. DNA microarrays were
printed and hybridized essentially as described by Wang et al. (2002),
with the following modiﬁcations: for array printing, a single-deﬁned
70mer (spike-70) was mixed with each viral oligonucleotide in a 1:50
ratio. Array hybridizations used Cy5-labeled ampliﬁed probe from
either virally infected cultures or controls (mock-infected culture,
HeLa RNA, or water); a reference signal for every spot on each array
was generated by using a Cy3-labeled version of the reverse
complement of spike-70. Oligonucleotides were assessed by Cy5
intensity. Oligonucleotides from the astrovirus and coronavirus
families that passed a conservative, arbitrarily set cutoff of
(Cy5infection-Cy5mock) . 1500 intensity units are listed in Table 1.
Additional oligonucleotides from these families and their homology
to the SARS coronavirus are listed in Table S1, found at http://
dx.doi.org/10.1371/journal.pbio.0000002.st001. Array data has been
deposited in the Gene Expression Omnibus (GEO) database
(accession number GSE546). A complete list of the viral oligonucleo-
tide sequences on the microarray is also available as Table S2, found
at http://dx.doi.org/10.1371/journal.pbio.0000002.st002.
Figure 2. Viral DNA Recovery and Sequencing Scheme
Hybridized viral sequences were physically scraped from a DNA microarray spot, ampliﬁed, cloned, and subsequently sequenced.
DOI: 10.1371/journal.pbio.0000002.g002
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were designed by aligning the hybridizing oligonucleotides (Oligo IDs
15081544_766 and 12175745_728) to the IBV genome (Fwd: 59-
TGTTTTGGAATTGTAATGTGGAT; Rev: 59-TACAAACTACCTCCA-
TTACAGCC) and selecting stretches of near-identity. Primer-B-
ampliﬁed material was used as the template for 35 cycles of
thermocycling using the following program: 948C for 30 s, 568C for
30 s, and 728C for 60 s.
Direct sequence recovery from the microarray. Ampliﬁed viral
sequences hybridized to individual microarray spots were recovered
by scraping a 100 lm area of the microarray using a tungsten wire
probe (Omega Engineering, Inc.) mounted on a micromanipulator
while visualized by ﬂuorescence microscopy (Nikon TE300). Recov-
ered material was PCR ampliﬁed using primer-B, cloned into
pCR2.1TOPO (Invitrogen), and sequenced. A detailed protocol is
available as Protocol S2, found at http://dx.doi.org/10.1371/journal.-
pbio.0000002.sd3.
Shotgun sequencing. Primer-B-ampliﬁed nucleic acid (see above)
was cloned in pCR2.1TOPO, plated on 2xYT/kan plates, and grown
overnight at 378C. White colonies were picked into 384-well plates
containing 2xYT/kan plus 8% glycerol and incubated overnight at
378C. DNA was puriﬁed by magnetic bead isolation. DNA sequencing
involved adding 3 ll of water to each bead pellet, followed by 3 llo f
Big Dye terminator (v3.1) sequencing cocktail, and incubation for 35
cycles of 958C for 5 s, 508C for 5 s, and 608C for 2 min. Reaction
products were ethanol precipitated, resuspended in 25 ll of water,
and loaded onto the ABI 3730xl sequencer. The resulting sequence
reads were trimmed to remove primer sequences from the RT-PCR
step and then assembled by Phrap (P. Green, unpublished data).
Resulting contigs were screened by blast to remove any contigs with
high human or monkey sequence similarity. The remaining contigs
were edited to high quality, making any obvious joins. (Sequences are
available as Data S1.)
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Note Added in Proof
The correct sequences for Primer A and Primer B are 59-GTTTCCCAGT-
CACGATANNNNNNNNN and 59-GTTTCCCAGTCACGATA, respectively.
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